US2014045755A1PendingUtilityA1

Methods for treating sleep disorders by cholecystokinin (cck) receptor b antagonists

55
Assignee: UNIV ILLINOISPriority: Jun 6, 2005Filed: Oct 21, 2013Published: Feb 13, 2014
Est. expiryJun 6, 2025(expired)· nominal 20-yr term from priority
Inventors:David W. CarleyMiodrag Radulovacki
A61P 43/00A61P 27/00A61P 25/00A61P 11/00A61K 45/06A61K 38/2207A61K 31/5513
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a method for preventing or ameliorating a sleep-related breathing disorder. The method involves the use of one or a combination of cholecystokinin (CCK) receptor antagonists.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for preventing or ameliorating a sleep-related breathing disorder comprising administering an effective amount of at least one cholecystokinin (CCK) receptor antagonist to a subject in need of treatment thereby preventing or ameliorating the subject's sleep-related breathing disorder. 
     
     
         2 . The method of  claim 1 , further comprising administering at least one other sleep-related breathing disorder therapeutic agent.

Join the waitlist — get patent alerts

Track US2014045755A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.